bupivacaine has been researched along with Mucositis in 2 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Mucositis: An INFLAMMATION of the MUCOSA with burning or tingling sensation. It is characterized by atrophy of the squamous EPITHELIUM, vascular damage, inflammatory infiltration, and ulceration. It usually occurs at the mucous lining of the MOUTH, the GASTROINTESTINAL TRACT or the airway due to chemical irritations, CHEMOTHERAPY, or radiation therapy (RADIOTHERAPY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim was to investigate systemic exposure after administration of a novel bupivacaine lozenge in healthy individuals with normal mucosa and in head and neck cancer (HNC) patients with oral mucositis." | 9.24 | Absorption of Bupivacaine after Administration of a Lozenge as Topical Treatment for Pain from Oral Mucositis. ( Andersen, O; Jacobsen, J; Jensen, AB; Jensen, K; Kreilgaard, M; Kristensen, CA; Mogensen, S; Petersen, J; Sveinsdóttir, K; Sverrisdóttir, E; Treldal, C, 2017) |
| "The aim was to investigate systemic exposure after administration of a novel bupivacaine lozenge in healthy individuals with normal mucosa and in head and neck cancer (HNC) patients with oral mucositis." | 5.24 | Absorption of Bupivacaine after Administration of a Lozenge as Topical Treatment for Pain from Oral Mucositis. ( Andersen, O; Jacobsen, J; Jensen, AB; Jensen, K; Kreilgaard, M; Kristensen, CA; Mogensen, S; Petersen, J; Sveinsdóttir, K; Sverrisdóttir, E; Treldal, C, 2017) |
| "Here, pancreatic cancer and treatment associated pain are reviewed along with current treatment strategies." | 2.66 | Pathogenesis and Treatment of Pancreatic Cancer Related Pain. ( Brothers, SP; Lohse, I, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lohse, I | 1 |
| Brothers, SP | 1 |
| Mogensen, S | 1 |
| Sverrisdóttir, E | 1 |
| Sveinsdóttir, K | 1 |
| Treldal, C | 1 |
| Jensen, K | 1 |
| Jensen, AB | 1 |
| Kristensen, CA | 1 |
| Jacobsen, J | 1 |
| Kreilgaard, M | 1 |
| Petersen, J | 1 |
| Andersen, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Topical Bupivacaine Effect On The Response To Awake Extubation During Emergence From General Anesthesia In Patients Undergoing Elective Thyroidectomy. A Randomized Controlled Study[NCT04471597] | 48 participants (Actual) | Interventional | 2020-07-20 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bupivacaine and Mucositis
| Article | Year |
|---|---|
Pathogenesis and Treatment of Pancreatic Cancer Related Pain.
Topics: Abdominal Pain; Analgesics, Opioid; Bupivacaine; Cancer Pain; Cisplatin; Humans; Mucositis; Pain Man | 2020 |
1 trial available for bupivacaine and Mucositis
| Article | Year |
|---|---|
Absorption of Bupivacaine after Administration of a Lozenge as Topical Treatment for Pain from Oral Mucositis.
Topics: Administration, Mucosal; Adult; Anesthetics, Local; Biological Availability; Bupivacaine; Dose-Respo | 2017 |